awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q31074302-5250FBF5-7BB4-4D9C-A314-43C8BFC06836
Q31074302-5250FBF5-7BB4-4D9C-A314-43C8BFC06836
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31074302-5250FBF5-7BB4-4D9C-A314-43C8BFC06836
Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, ra
P2860
Q31074302-5250FBF5-7BB4-4D9C-A314-43C8BFC06836
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31074302-5250FBF5-7BB4-4D9C-A314-43C8BFC06836
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8261bb671526c92efcbefaedc185088542793d91
P2860
Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysis.